Introduction {#S0001}
============

Thirty-day mortality is increasingly used to measure and compare health care performance and quality across hospitals, as it is easily understood, clearly defined, universally resonant for patients, clinicians, and managers and is considered to convey key elements of health care.[@CIT0001],[@CIT0002] The implicit assumption is that the variation in this patient outcome measure reflects variation in hospital policies and practices that are within hospitals' control. Outcome measures are especially used within surgery including orthopedic surgeries, which only to a limited extent have used process performance measures to reflect health care performance.

The results from such hospital comparisons are applied for benchmarking, including sanctions or rewards to specific hospitals, as well as for internal quality improvement initiatives based on the plan-do-study-act principle.[@CIT0003] However, hospital comparisons may also lead to stigmatizing hospitals with the highest mortality rates. Sound methodology and reliable estimates are therefore crucial when ranking hospitals.[@CIT0004]--[@CIT0006] Although ranking hospitals on their average mortality are easy to do, such rankings are naïve as any sense of the difference in mortality rates between rankings is lost and the substantial role of chance variability in driving mortality rates and therefore rankings in hospitals with small numbers of patients is ignored.[@CIT0007] More fundamentally, hospital comparisons must account for variation in case-mix across different hospitals which strongly predicts patient outcomes and therefore variation in unadjusted hospital mean outcomes.[@CIT0004],[@CIT0005],[@CIT0008]--[@CIT0010]

The multilevel approach to studying variation in patient outcomes decomposes any variation unexplained by the covariates into separate variance components operating at the patient and hospital levels of analysis.[@CIT0006],[@CIT0011]--[@CIT0015] Thus, the hospital variance component, often referred to as the hospital general context effect, quantifies the share of the total individual variation in 30-day mortality that lies at the hospital level over and above differences in patient characteristics. In addition, multilevel models also provide a better approach for handling the unreliable data that arise from small hospital caseloads and therefore for detecting true hospital quality differences compared to their fixed-effects model counterparts.[@CIT0010],[@CIT0012]--[@CIT0014]

Previous studies within surgery using multilevel models have focused on the reliability of ranking hospitals, but no previous studies have obtained reliability-weighted estimates of hospital average rates of hip fracture mortality, although hip fracture is often used as a tracer condition for hospital performance.[@CIT0016] In this article, we, therefore, pursue two aims. Our first aim is to obtain reliability-weighted estimates of hospital average rates that take into account hospital differences in patient load to examine the amount of differences. Our second aim is to quantify the size of the hospital general contextual effect, to examine to what extent the variation in mortality is attributable to differences at the hospital level.

Population and methods {#S0002}
======================

This historical follow-up study is based on prospectively collected data available from medical registries in Denmark (5.8 million inhabitants) with free access to medical care.[@CIT0017] At birth or upon immigration, all citizens in Denmark are assigned a unique registration number through which all contact with the health care system is recorded. This allows unambiguous record linkage between registries.[@CIT0018] The study was approved by the Danish Data Protection Agency (journal number 2012--41-1274).

Data sources {#S0002-S2001}
------------

The Danish Multidisciplinary Hip Fracture Registry (DMHFR) was used to identify a cohort of hip fracture patients.[@CIT0019] The DMHFR was established in 2003 to document and improve care quality and the registry includes data on all patients age ≥65 admitted with femoral fractures (International Classification of Diseases 10th revision codes) medial (DS720), pertrochanteric (DS721), or subtrochanteric (DS722) treated surgically according to the Classification for Surgical Procedures (codes) with osteosynthesis (KNFJ) or alloplastic (KNFB).[@CIT0020]

DMHFR is a national clinical quality register and contains patient-level data on process performance measures reflecting current guidelines for in-hospital hip fracture care. The register also contains sociodemographic and clinical characteristics. Reporting to the registry is mandatory by law for all hospital departments treating hip fracture patients and data are recorded prospectively by the care staff starting from patient admission.[@CIT0019]

The study database was then complemented with information from the nationwide administrative Danish National Patient Registry (DNPR), which holds data on all non-psychiatric hospital admissions since 1977 and on all outpatient and emergency visits since 1995, recorded according to the International Classification of Diseases (Eight Revision, ICD-9) until the end of 1993 and Tenth Revision (ICD-10) thereafter.[@CIT0018]

We also linked the study database to the Danish Civil Registry System (DCRS), which has maintained electronic records of changes in vital status and migration for the entire Danish population since 1968, which allow complete follow-up on mortality in this study.[@CIT0018]

Finally, we included demographic and socioeconomic information from Statistic Denmark. Statistic Denmark is a collection of register data, which contains detailed statistical information on residents in Denmark and the Danish society.[@CIT0021],[@CIT0022] These registers are updated yearly.

Study population {#S0002-S2002}
----------------

We identified all first time hospitalizations for hip fracture patients registered in the DMHFR with a discharge date between 2007 and 2016 (N=65,931). We excluded patients with more than one hip fracture during the study period (N=4092), so we only include the first admission for hip fracture in the study cohort. Further, we excluded patients residing less than five years in Denmark prior to the hip fracture surgery date (N=199) because of insufficient information on previous income and comorbidity in the Danish registries. We also excluded 1,636 patients for the following reasons; missing hip fracture surgery code, patients without a registered address, double registration, patients treated in January and February 2010 due to change in reporting system and patients registered at hospital departments with less than 10 hip fracture patients per year. The final study cohort included 60,004 patients ([Figure 1](#F0001){ref-type="fig"}).Figure 1Flowchart patient inclusion.

Assessment of variables {#S0002-S2003}
-----------------------

### Outcome variables {#S0002-S2003-S3001}

We investigated all-cause mortality within 30 days based on data from DCRS.

### Patient characteristics {#S0002-S2003-S3002}

In the analysis, we wish to interpret hospital differences, but part of these differences relates to selection bias that confounds the comparison between hospitals. To make the observational measurement of hospital effects as valid as possible we therefore, adjust for potential differences in patient sociodemographic and biomedical characteristics ([Table 1](#T0001){ref-type="table"}).[@CIT0023],[@CIT0024]Table 1Characteristic of the hip fracture population**Overall 30-day mortality**10%**Number of patients in the population**60,004**Number of hospitals**32**Median number of patients at the hospital (min--max)**143--4,193**Age group (years)**65--74 (reference)19%11,63175--8438%22,554\>8543%25,819**Gender**Men29%17,158Women (reference)71%42,846**BMI (kg/m^2^)**\<19: Underweight13%7,50320--25: Normal (reference)48%28,796\>26: Overweight22%13,352Missing17%10,353**CCI**0 point: No comorbidity (reference)18%10,8901 point: Low comorbidity23%13,8262 points: Moderate comorbidity20%12,246+3 points: High comorbidity38%23,042**Fracture type**Undisplaced femoral neck (reference)39%23,508Displaced femoral neck8%4,582Unspecified femoral neck6%3,712Pertrochanteric40%23,802Subtrochanteric7%4,400**Education**Ground school (reference)49%29,326More than ground school25%15,032University degree9%5,313Missing17%10,333**Family mean income**Low (reference)33%19,905Medium33%20,010High34%20,089**Migration status**Immigrant3%1,783Native (reference)97%58,221**Cohabiting status**Living alone (reference)63%37,936Living together37%22,068**Employment status**Retired (reference)90%53,946Employed2%1,436Missing8%4,622**Fragility**Nursing home residence14%8,554Living in own home (reference)86%51,450[^1]

### Sociodemographic characteristics {#S0002-S2003-S3003}

Age (65--75 years, 75--85 years, and \>85 years) and sex were classified according to criteria used at the DMHFR. We categorized individualized family income into four groups by quartiles of increasing income.[@CIT0025] To account for yearly variation in family income, we calculated the average yearly total income in the five years before admission for the patient and cohabiting partner. We classified education achievement into (i) elementary school (7 years), (ii) more than elementary school, (iii) university degree, and (iv) missing values.[@CIT0025] We dichotomized the country of birth of the patients into migrant vs native and their cohabiting status into living alone vs living together. We classified employment status into (i) retired, (ii) employed, and (iii) missing values. To simplify the model and decrease the likelihood of non-convergence, which may be a problem when including multiple covariates in multilevel models, we combined sociodemographic characteristics into a single patient risk score. Using a conventional logistic regression analysis we estimated the individual patient´s *sociodemographic risk score* (predicted probability) for all-cause mortality based on sex, age, family income, education, migration, employment, and cohabitation status. The sociodemographic risk scores were then categorized into four groups by quartiles as low, medium, high, and very high. The low-risk score group was then used as the reference in the comparisons.

### Biomedical characteristics {#S0002-S2003-S3004}

The body mass index (BMI) in kg/m^2^ and the type of hip fracture were classified according to criteria used at the DMHFR ([Table 1](#T0001){ref-type="table"}). We summarized the complete comorbidity history of each patient. We ascertained all diagnoses included in the Charlson comorbidity index (CCI) during the last 10 years including the admission for hip fracture.[@CIT0026] The CCI is a method of categorizing comorbidities of patients based on ICD diagnosis codes from DNPR. Each comorbidity category has an associated weight, based on the adjusted risk of mortality or resource use, and the sum of all the weights results in a single comorbidity score for a patient that ranges from 1 to 6 points. The higher the score, the higher the level of comorbidity and thereby the mortality risk. We categorized the CCI into, no comorbidity (0 points), low comorbidity (1 point), moderate comorbidity (2 points), and high comorbidity (≥3 points). We also included a dichotomous variable distinguishing if the patient was living in nursing home residence or living in own home.

Statistical analysis {#S0002-S2004}
--------------------

We estimated the cumulative risk for 30-day mortality. To quantify the variation in this outcome across the 32 hospitals and to disentangle hospitals from patient influences, we applied a stepwise-multilevel, logistic regression analysis of discriminatory accuracy with patients nested in hospitals.[@CIT0011] We developed three consecutive logistic regression analyses. For each model, we calculated the predicted probability of death and then used this to compute the Receiving Operator Characteristics Curve and to calculate the area under this curve (AUC).[@CIT0027] The AUC measures the ability of the model to correctly classify individuals with or without the outcome.

Model 1 was a simple conventional logistic regression aimed to evaluate the influence of patients' demographic and socioeconomic characteristics on the outcome using the sociodemographic risk score groups. We calculated the AUC~1~.

Model 2 added the biomedical characteristics of the patients including BMI, CCI, frailty, and fracture type. We calculated the AUC~2~ and in order to quantify the value added of the biomedical information compared to only using sociodemographic information we obtained the increment in the AUC (AUC~2~ − AUC~1~).

Model 3 was a multilevel logistic regression model which included a random intercept for the 32 hospitals. This model aimed to isolate the contribution of the hospital to the individual risk of 30-day mortality. To quantify the variation in 30-day mortality across hospitals, we estimated the absolute risk of 30-day mortality and its 95% confidence intervals (CI) for each hospital by transformation of the results from the multilevel logistic regression to the probability scale. The absolute risk for each hospital was calculated as a function of both the sample average patient case -mix (the estimated fixed part of the model where the covariates are held at their average values) and the hospital attended (the predicted hospital random effect). This answers the question: how would mortality rates vary across hospitals if all hospitals had exactly the same case-mix where that case-mix matches the overall average case-mix in the data? The predicted hospital random effects provide reliability-weighted estimates of the hospital average risks. To illustrate adjusted absolute risk differences between hospitals, we created league tables by ranking hospitals according to their absolute risk. Model 3 also aimed to examine the size of the hospital general contextual effect in order to answer to what extent the variation in mortality was attributable to differences in patient characteristics or the hospital context. Besides the changes in AUC (AUC~3~ -- AUC~2~), we used standard summary statistics including the intraclass correlation coefficient (ICC) and median odds ratio (MOR). The ICC is a measure of clustering that informs on the magnitude the correlation in the propensity for an outcome (having adjusted for the covariates) between two individuals, who are treated at the same hospital. This statistic can also be interpreted as a variance partition coefficient (VPC),[@CIT0028]--[@CIT0030] namely the proportion of adjusted individual outcome variation that lies between hospitals. These statistics are derived from the latent response formulation of the logistic regression model where the patient-level residuals follow a logistic distribution with a constant variance of 3.29.[@CIT0031] The formula of the VPC/ICC is $$\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{VPC}} \equiv {\rm{ICC}} = {{\sigma _u^2} \over {\sigma _u^2 + 3.29}}$$
\end{document}$$

where $\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$$\sigma _u^2$$
\end{document}$ represent the hospital variance. The MOR is a measure of heterogeneity between hospitals. The MOR translates the hospital variance estimated on the log-odds scale, to the widely used OR scale, which makes it comparable with the OR of the covariates in the fixed part of the model. The MOR is defined as the median value of the distribution of ORs obtained when randomly picking two individuals with the same covariate values from two different hospitals, and comparing the one from the higher risk hospital to the one from the lower risk hospital. In simple terms, the MOR can be interpreted as the median increased odds of mortality if an individual was treated in another hospital with higher risk. The MOR is calculated as $$\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{MOR}} = \exp \left\{ {\sqrt {2\sigma _u^2{\ }} {{\rm{\Phi }}^{ - 1}}\left({0.75} \right)} \right\}$$
\end{document}$$

where $\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${{\rm{\Phi }}^{ - 1}}\left(\cdot \right)$$
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We performed a likelihood ratio test to test for whether we were able to detect statistically significant differences between the 32 hospitals.

We performed the analyses using maximum likelihood estimation (via adaptive quadrature) as implemented in the melogit command in Stata (StataCorp., 2014).[@CIT0032]

Results {#S0003}
=======

Characteristics of the hip fracture population {#S0003-S2001}
----------------------------------------------

The overall 30-day mortality rate in the cohort was 10%. The hip fracture patients in our cohort were mainly above 85 years and the majority were women. Most of the patients had an undisplaced femoral neck fracture or a pertrochanteric hip fracture. The additional characteristics of the hip fracture patients are described in [Table 1](#T0001){ref-type="table"}.

Patient effects {#S0003-S2002}
---------------

The sociodemographic risk score was clearly associated with 30-day mortality ([Table 2](#T0002){ref-type="table"}). Also, underweight patients and, especially, patients with missing information on BMI presented a higher risk of 30-day mortality. Comorbidity, as captured by the CCI, as well as frailty, both increased 30-day mortality risk. Patients with a subtrochanteric femur fracture presented an increased mortality risk whereas patients with a displaced femoral neck fracture have lower mortality risk. The AUC~1~ in model 1, which informs on the discriminatory accuracy of the sociodemographic information, had a value of 0.67 (95% CI: 0.66--0.68) ([Table 2](#T0002){ref-type="table"}). Including the biomedical characteristics of the patients (model 2) increased the AUC to 0.73 (95% CI: 0.72--0.73).Table 2Variation in 30-day mortalitySimple logistic regression analysisMultilevel logistic regression analysisModel 1Model 2Model 3**Specific individual average effectsSociodemographic score** Low1.001.001.00 Medium1.73(1.56--1.92)1.60(1.44--1.78)1.60(1.44--1.78) High3.11(2.82--3.43)2.70(2.44--2.98)2.69(2.44--2.97) Very high5.80(5.29--6.36)5.07(4.62--5.58)5.10(4.64--5.61)**BMI^a^ (kg/m^2^)** \<19: Underweight1.59(1.46--1.72)1.60(1.54--1.82) 20--25: Normal (ref.)1.001.00 \>26: Overweight0.68(0.63--0.74)0.69(0.63--0.74) Missing1.88(1.76--2.02)2.03(1.88--2.18)**CCI^b^** 0 point: No comorbidity (ref.)1.001.00 1 point: Low comorbidity1.29(1.17--1.42)1.30(1.18--1.43) 2 points: Moderate comorbidity1.32(1.20--1.45)1.34(1.21--1.47) +3 points: High comorbidity1.63(1.50--1.78)1.65(1.51--1.80)**Fracture type** Undisplaced femoral neck (reference)1.001.00 Displaced femoral neck0.76(0.67--0.86)0.77(0.68--0.87) Unspecified femoral neck0.99(0.88--1.11)0.98(0.87--1.10) Pertrochanteric1.04(0.98--1.10)1.04(0.98--1.11) Subtrochanteric1.22(1.09--1.35)1.23(1.10--1.37)**Frailty** Nursing home residence vs living in own home2.28(2.14--2.43)2.29(2.15--2.44)**General contextual effects**Hospital variance0.0290(0.0151--0.0559)VPC^c^/ICC^d^ hospital (%)0.87(0.46--1.67)MOR hospital1.18(1.12--1.25)AUC0.671(0.665--0.678)0.728(0.721--0.734)0.732(0.725--0.738)$\documentclass[12pt]{minimal}
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Hospital effects {#S0003-S2003}
----------------

The unadjusted 30-day mortality varied from 8% to 12% across the 32 hospitals ([Figure 2](#F0002){ref-type="fig"}). The adjusted differences between hospital averages in mortality extended from 5% to 9% ([Figure 3](#F0003){ref-type="fig"}). [Figure 3](#F0003){ref-type="fig"} shows that the hospital with the highest absolute risk has an average mortality risk 1.8 times higher than the hospital with the lowest absolute risk. Similarly, the hospital variance, indicated by the MOR, showed an increased adjusted odds of dying within 30 days of 1.18 (95% CI: 1.12--1.25) if a patient was admitted to high-risk hospital compared to a low-risk hospital. However, the clustering of hip fracture patients within the 32 hospitals was small, as the VPC was 0.87% (95% CI: 0.46--1.67%), indicating that less than 1% of the adjusted individual variance in the underlying propensity of death was at the hospital level. A likelihood ratio test showed that these hospital differences while substantively small were statistically significant. Similarly, the AUC in model 3, which included the hospital level, only increased marginally by 0.004 points, when compared with the single-level model (model 2) ([Table 2](#T0002){ref-type="table"}).Figure 2League table ranking the 32 hospitals according to their unadjusted absolute risk of 30-day mortality with 95 % confidence intervals obtained from a multilevel model.Figure 3League table ranking the 32 hospitals according to their adjusted absolute risk of 30-day mortality with 95 % confidence intervals obtained from a multilevel model adjusted by patient-mix.

Discussion {#S0004}
==========

In this nationwide population-based study of hip fracture patients, the overall 30-day mortality rate was 10%. Patient factors including sociodemographic characteristics, underweight, comorbidity, and suffering from a subtrochanteric hip fracture were strong predictors of 30-day mortality (AUC=0.728). The adjusted hospital differences in 30-day mortality rates varied from 5% to 9% across the 32 hospitals. However, the multilevel analysis revealed that hospital-level variation corresponded to less than 1% of the overall individual variation in the underlying propensity of death.

Still, some hospitals presented a higher average absolute risk than others and the adjusted mortality rate was 1.8 times higher at the top than at the bottom of the hospital league table. The existence of hospital differences in average absolute risks may suggest that there is a place for some improvement by focusing on the hospitals at the higher extreme of the absolute risk distribution. However, the fact that most of the variance is related to known patient-level characteristics (AUC=0.728 in model 2) and that the hospital general context effect is very low argues against hospital-level interventions. Instead, health care systems should focus on improving care at the patient level as indicated by the substantial individual-level variation in 30-day mortality observed in our study.

Nationwide studies from Sweden and England among hip fracture patients observed an overall 30-day mortality rate below 8% compared to the Danish 10%.[@CIT0033],[@CIT0034] One potential explanation of the higher mortality in Denmark could be the lack of adherence to clinical guidelines observed in the Danish Multidisciplinary Hip Fracture Registry.[@CIT0035] Interestingly, in the UK, 30-day mortality after hip fracture is lower than in Denmark but the UK has a higher fulfillment of nearly identical process performance measures.[@CIT0036],[@CIT0037] Compliance with guideline recommended process performance measures are associated with lower mortality[@CIT0038],[@CIT0039] as well as unchanged or even lower hospital cost.[@CIT0040]

The low variation at the hospital level, when examining outcome measures, is comparable to previous multilevel studies within other areas which have focused on rankability and reliability.[@CIT0004],[@CIT0010] Our study is therefore in accordance with these existing studies when questioning the use of continuous monitoring outcome measures as a mirrored image of the health care quality delivered at hospitals. Lilford et al,[@CIT0003] have pointed out that differences in health care are likely to be lost when using outcome indicators (eg, mortality), due to poor correlation between processes and outcomes and the inherent problem of confounding. However, as opposed to the existing studies, we quantified the size of the hospital differences as we have applied a comprehensive perspective which at the same time considers both hospital differences and patient differences including their relative importance instead of considering them as two separate and unrelated phenomena of interest. The fact that 30-day mortality and other related measures are routinely used even though there is a very little hospital-level variation calls for reflection. A more systematic evaluation of the relevance and usability of performance measures seems warranted in general and for generic outcome performance measures like 30-day mortality in particular if efforts invested in quality improvement work are to be effective. Advanced analytical approaches may be useful in this context as exemplified in our study.

Methodological considerations {#S0004-S2001}
-----------------------------

Our results should be evaluated in light of several limitations. First, patient characteristics may have differed in ways that were not captured by the registries. However, to minimize confounding we adjusted for a range of well-established prognostic factors and the resulting AUC was moderate at 0.73.

Secondly, the multilevel approach is more conservative in identifying outliers compared to, conventional logistic regression which enters hospitals as dummy variables (ie, fixed-effect models), which have greater sensitivity. As opposed to this, the multilevel approach (ie, random-effect models) has higher specificity and is less susceptible to biased estimation by random variation if the number of patients in some hospitals is low.[@CIT0012],[@CIT0041]

Thirdly, the length of hospital stay has decreased in our health care systems, which includes early discharge of patients to their own home with support from the municipality. The variation among hospitals in 30-day mortality therefore likely expresses the integrated performance of both hospital and municipality care. However, the analysis demonstrated that the hospital variance component in any case was very small in magnitude.

Conclusion {#S0005}
==========

In conclusion, the adjusted differences between hospital 30-day mortality rates varied from 5% to 9%. However, less than 1% of the patient variation in adjusted propensity of death within 30 days operated between hospitals. To reduce 30-day mortality among hip fracture patients, we should focus on improving the care for the most vulnerable patients. A feasible way of improving care without increasing the health care cost is to focus on the implementation of basic health care processes reflecting clinical guideline recommendations. The hospital level is fundamental in hip fracture care, but our results suggest that interventions to ensure high care quality should be universal rather than focused on specific hospitals.
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[^1]: **Abbreviations:** BMI, body mass index; CCI, Charlson comorbidity index.

[^2]: **Notes:** ^a^Model 1: Simple logistic regression model adjusted for socioeconomic risk score. ^b^Model 2: Simple logistic regression model adjusted for socioeconomic risk score and biomedical characteristics of the patient. ^c^Model 3: Multilevel logistic regression model. ^d^Model 4: Multilevel logistic regression model adjusted for socioeconomic risk score and biomedical characteristics of the patient and hospital as random effect.

[^3]: **Abbreviations:** BMI, body mass index; CCI, Charlson comorbidity index; VPC, variance partition Coefficient; ICC, intra class correlation coefficient, MOR, median odds ratio, AUC, area under the receiver operating characteristic curve.
